Session

Breakthroughs in GORD and functional dyspepsia (Posters)

A NOVEL ROLE FOR HIGH MOBILITY GROUP BOX 1 (HMGB1) IN GASTRO-OESOPHAGEAL REFLUX DISEASE
A NOVEL ROLE FOR HIGH MOBILITY GROUP BOX 1 (HMGB1) IN GASTRO-OESOPHAGEAL REFLUX DISEASE

Breakthroughs in GORD and functional dyspepsia (Posters)  et al.

THE ROLE OF TENASCIN-X IN IDIOPATHIC GASTROPARESIS: WGS ANALYSIS
THE ROLE OF TENASCIN-X IN IDIOPATHIC GASTROPARESIS: WGS ANALYSIS

Breakthroughs in GORD and functional dyspepsia (Posters)

EFFECT OF IBEROGAST N (STW5-II) ON TRANSIT AND TOLERANCE TO GASTRIC GAS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA
EFFECT OF IBEROGAST N (STW5-II) ON TRANSIT AND TOLERANCE TO GASTRIC GAS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA

Breakthroughs in GORD and functional dyspepsia (Posters)  et al.

BRAIN ACTIVITY IN RESPONSE TO FOOD VISUAL STIMULI DETECTED BY INFRARED SPECTROSCOPY AND AN ARTIFICIAL INTELLIGENCE-BASED DIAGNOSIS SUPPORT SYSTEM IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA
BRAIN ACTIVITY IN RESPONSE TO FOOD VISUAL STIMULI DETECTED BY INFRARED SPECTROSCOPY AND AN ARTIFICIAL INTELLIGENCE-BASED DIAGNOSIS SUPPORT SYSTEM IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA

Breakthroughs in GORD and functional dyspepsia (Posters)  et al.

CONVENTIONAL VERSUS OBLIQUE FIBERS SPARING ENDOSCOPIC MYOTOMY FOR ACHALASIA CARDIA: A RANDOMIZED CONTROLLED TRIAL
CONVENTIONAL VERSUS OBLIQUE FIBERS SPARING ENDOSCOPIC MYOTOMY FOR ACHALASIA CARDIA: A RANDOMIZED CONTROLLED TRIAL

Breakthroughs in GORD and functional dyspepsia (Posters)  et al.

EFFICACY OF AN ORAL SOLUTION CONTAINING XYLOGLUCAN AND PEA PROTEINS ON A MURINE MODEL OF GASTROESOPHAGEAL REFLUX DISEASE
EFFICACY OF AN ORAL SOLUTION CONTAINING XYLOGLUCAN AND PEA PROTEINS ON A MURINE MODEL OF GASTROESOPHAGEAL REFLUX DISEASE

Breakthroughs in GORD and functional dyspepsia (Posters)  et al.

LINAPRAZAN GLURATE IS HIGHLY EFFECTIVE IN TREATING MODERATE TO SEVERE EROSIVE ESOPHAGITIS: A DOUBLE-BLIND, RANDOMIZED, DOSE FINDING STUDY
LINAPRAZAN GLURATE IS HIGHLY EFFECTIVE IN TREATING MODERATE TO SEVERE EROSIVE ESOPHAGITIS: A DOUBLE-BLIND, RANDOMIZED, DOSE FINDING STUDY

Breakthroughs in GORD and functional dyspepsia (Posters)  et al.

DUODENAL BUT NOT FAECAL EOSINOPHIL DERIVED NEUROTOXIN IS ASSOCIATED WITH DUODENAL EOSINOPHILS IN FUNCTIONAL DYSPEPSIA
DUODENAL BUT NOT FAECAL EOSINOPHIL DERIVED NEUROTOXIN IS ASSOCIATED WITH DUODENAL EOSINOPHILS IN FUNCTIONAL DYSPEPSIA

Breakthroughs in GORD and functional dyspepsia (Posters)  et al.

CLINICAL OUTCOMES OF ANTI-REFLUX MUCOSAL ABLATION (ARMA) FOR GASTROESOPHAGEAL REFLUX DISEASE: AN INTERNATIONAL BI-INSTITUTIONAL STUDY
CLINICAL OUTCOMES OF ANTI-REFLUX MUCOSAL ABLATION (ARMA) FOR GASTROESOPHAGEAL REFLUX DISEASE: AN INTERNATIONAL BI-INSTITUTIONAL STUDY

Breakthroughs in GORD and functional dyspepsia (Posters)  et al.

SPECIFIC PATIENT PHENOTYPING IN GASTRODUODENAL DISORDERS USING GASTRIC ALIMETRY® WITH COMPARISON TO GASTRIC EMPTYING SCINTIGRAPHY
SPECIFIC PATIENT PHENOTYPING IN GASTRODUODENAL DISORDERS USING GASTRIC ALIMETRY® WITH COMPARISON TO GASTRIC EMPTYING SCINTIGRAPHY

Breakthroughs in GORD and functional dyspepsia (Posters)  et al.

SPECIFIC PATIENT PHENOTYPING IN GASTRODUODENAL DISORDERS USING GASTRIC ALIMETRY® WITH COMPARISON TO GASTRIC EMPTYING SCINTIGRAPHY
SPECIFIC PATIENT PHENOTYPING IN GASTRODUODENAL DISORDERS USING GASTRIC ALIMETRY® WITH COMPARISON TO GASTRIC EMPTYING SCINTIGRAPHY

THE ROLE OF TENASCIN-X IN IDIOPATHIC GASTROPARESIS: WGS ANALYSIS
THE ROLE OF TENASCIN-X IN IDIOPATHIC GASTROPARESIS: WGS ANALYSIS

DUODENAL BUT NOT FAECAL EOSINOPHIL DERIVED NEUROTOXIN IS ASSOCIATED WITH DUODENAL EOSINOPHILS IN FUNCTIONAL DYSPEPSIA
DUODENAL BUT NOT FAECAL EOSINOPHIL DERIVED NEUROTOXIN IS ASSOCIATED WITH DUODENAL EOSINOPHILS IN FUNCTIONAL DYSPEPSIA

A NOVEL ROLE FOR HIGH MOBILITY GROUP BOX 1 (HMGB1) IN GASTRO-OESOPHAGEAL REFLUX DISEASE
A NOVEL ROLE FOR HIGH MOBILITY GROUP BOX 1 (HMGB1) IN GASTRO-OESOPHAGEAL REFLUX DISEASE

EFFECT OF IBEROGAST N (STW5-II) ON TRANSIT AND TOLERANCE TO GASTRIC GAS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA
EFFECT OF IBEROGAST N (STW5-II) ON TRANSIT AND TOLERANCE TO GASTRIC GAS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA

BRAIN ACTIVITY IN RESPONSE TO FOOD VISUAL STIMULI DETECTED BY INFRARED SPECTROSCOPY AND AN ARTIFICIAL INTELLIGENCE-BASED DIAGNOSIS SUPPORT SYSTEM IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA
BRAIN ACTIVITY IN RESPONSE TO FOOD VISUAL STIMULI DETECTED BY INFRARED SPECTROSCOPY AND AN ARTIFICIAL INTELLIGENCE-BASED DIAGNOSIS SUPPORT SYSTEM IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND FUNCTIONAL DYSPEPSIA

CONVENTIONAL VERSUS OBLIQUE FIBERS SPARING ENDOSCOPIC MYOTOMY FOR ACHALASIA CARDIA: A RANDOMIZED CONTROLLED TRIAL
CONVENTIONAL VERSUS OBLIQUE FIBERS SPARING ENDOSCOPIC MYOTOMY FOR ACHALASIA CARDIA: A RANDOMIZED CONTROLLED TRIAL

EFFICACY OF AN ORAL SOLUTION CONTAINING XYLOGLUCAN AND PEA PROTEINS ON A MURINE MODEL OF GASTROESOPHAGEAL REFLUX DISEASE
EFFICACY OF AN ORAL SOLUTION CONTAINING XYLOGLUCAN AND PEA PROTEINS ON A MURINE MODEL OF GASTROESOPHAGEAL REFLUX DISEASE

LINAPRAZAN GLURATE IS HIGHLY EFFECTIVE IN TREATING MODERATE TO SEVERE EROSIVE ESOPHAGITIS: A DOUBLE-BLIND, RANDOMIZED, DOSE FINDING STUDY
LINAPRAZAN GLURATE IS HIGHLY EFFECTIVE IN TREATING MODERATE TO SEVERE EROSIVE ESOPHAGITIS: A DOUBLE-BLIND, RANDOMIZED, DOSE FINDING STUDY

CLINICAL OUTCOMES OF ANTI-REFLUX MUCOSAL ABLATION (ARMA) FOR GASTROESOPHAGEAL REFLUX DISEASE: AN INTERNATIONAL BI-INSTITUTIONAL STUDY
CLINICAL OUTCOMES OF ANTI-REFLUX MUCOSAL ABLATION (ARMA) FOR GASTROESOPHAGEAL REFLUX DISEASE: AN INTERNATIONAL BI-INSTITUTIONAL STUDY

Item 1 - 20 / 20
1